Media Coverage
Discover the latest media coverage and articles featuring Neurogen Biomarking's innovative approach to early Alzheimer's detection.
Hundreds Attend Free Brain Health Day in Chicago to Combat Alzheimer's Disparities
Community event focused on addressing health disparities in Alzheimer's disease among underserved populations.
Read ArticleNeurogen Biomarking and Quanterix Collaborate on Early Alzheimer’s Detection
Neurogen Biomarking partners with Quanterix to utilize ultrasensitive blood biomarker technology for early Alzheimer's and MCI detection through at-home testing and telehealth services.
Read Article
Neurogen Biomarking and NeuroX Join Forces to Enhance Early Alzheimer’s Detection
Neurogen Biomarking teams up with NeuroX to integrate virtual neurology services, aiming to accelerate early Alzheimer's and MCI detection via telehealth and AI-driven assessments.
Read Article
Neurogen and NeuroX Partner to Advance Early Alzheimer’s Detection
Neurogen collaborates with NeuroX to transform early Alzheimer's identification through blood biomarker testing and AI-powered digital assessments, offering timely telehealth support.
Read Article
Empowering Early Alzheimer's Detection with At-Home Blood Testing
Dr. Rany Aburashed discusses Neurogen Biomarking's at-home blood test measuring p-tau 217, enabling Alzheimer's detection up to 10 years before symptoms appear.
Read Article
Neurogen and Linus Health Unite for Proactive Alzheimer's Care
Neurogen partners with Linus Health to integrate digital cognitive assessments and at-home biomarker testing, facilitating early detection and personalized care for Alzheimer's patients.
Read Article
Neurogen and Aranscia Collaborate to Advance Early Alzheimer's Detection
Neurogen partners with Aranscia to enhance blood-based Alzheimer's diagnostics, integrating lab support and HIPAA-compliant digital workflows for streamlined patient care.
Read Article